| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0033 | 1 |